Forefront Analytics, LLC - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 78 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is 13.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Forefront Analytics, LLC ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$61,175
+13.3%
164,894
+64.8%
0.03%
+13.8%
Q3 2022$54,000
-6.9%
100,041
+8.0%
0.03%
+3.6%
Q2 2022$58,000
-19.4%
92,641
-7.1%
0.03%
+3.7%
Q1 2022$72,000
+2.9%
99,741
+89.7%
0.03%
+17.4%
Q4 2021$70,000
-40.7%
52,566
+2.9%
0.02%
-46.5%
Q3 2021$118,000
+57.3%
51,066
+195.3%
0.04%
+43.3%
Q2 2021$75,000
-36.4%
17,291
+7.3%
0.03%
-40.0%
Q1 2021$118,000
-15.1%
16,110
-49.8%
0.05%
-16.7%
Q4 2020$139,000
+13.0%
32,090
+5.7%
0.06%
+5.3%
Q3 2020$123,000
+7.0%
30,369
+58.8%
0.06%
-18.6%
Q2 2020$115,00019,1300.07%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ORCHARD THERAPEUTICS PLC shareholders